IRIS
CONTI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.678
AS - Asia 9.333
EU - Europa 7.160
SA - Sud America 1.677
AF - Africa 534
Continente sconosciuto - Info sul continente non disponibili 221
OC - Oceania 8
Totale 31.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.208
SG - Singapore 3.477
CN - Cina 2.617
VN - Vietnam 1.568
BR - Brasile 1.293
DE - Germania 1.089
IE - Irlanda 1.082
IT - Italia 964
FI - Finlandia 874
UA - Ucraina 864
SE - Svezia 859
HK - Hong Kong 608
ZA - Sudafrica 382
FR - Francia 341
NL - Olanda 320
CA - Canada 292
TR - Turchia 214
BD - Bangladesh 199
GB - Regno Unito 196
AT - Austria 173
RU - Federazione Russa 143
AR - Argentina 133
IN - India 125
EC - Ecuador 77
JP - Giappone 75
MX - Messico 67
ES - Italia 55
ID - Indonesia 55
IQ - Iraq 54
CO - Colombia 49
VE - Venezuela 48
BE - Belgio 45
PH - Filippine 37
PK - Pakistan 36
KR - Corea 35
PL - Polonia 34
MA - Marocco 32
KE - Kenya 27
TW - Taiwan 27
PY - Paraguay 26
UZ - Uzbekistan 26
TH - Thailandia 25
CZ - Repubblica Ceca 23
EG - Egitto 23
SA - Arabia Saudita 21
CR - Costa Rica 20
IL - Israele 20
LT - Lituania 19
UY - Uruguay 17
JM - Giamaica 16
NP - Nepal 16
NI - Nicaragua 15
JO - Giordania 14
CL - Cile 12
EU - Europa 12
TN - Tunisia 12
TT - Trinidad e Tobago 12
AZ - Azerbaigian 11
CI - Costa d'Avorio 11
AE - Emirati Arabi Uniti 10
BO - Bolivia 9
PE - Perù 9
HN - Honduras 8
BG - Bulgaria 7
CH - Svizzera 7
RO - Romania 7
SV - El Salvador 7
ET - Etiopia 6
GT - Guatemala 6
HU - Ungheria 6
KZ - Kazakistan 6
LB - Libano 6
MY - Malesia 6
OM - Oman 6
PA - Panama 6
PS - Palestinian Territory 6
RS - Serbia 6
BH - Bahrain 5
BJ - Benin 5
BY - Bielorussia 5
DK - Danimarca 5
AO - Angola 4
AU - Australia 4
BB - Barbados 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EE - Estonia 4
GP - Guadalupe 4
KW - Kuwait 4
PT - Portogallo 4
TG - Togo 4
AL - Albania 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
CY - Cipro 3
GD - Grenada 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
Totale 31.336
Salva come PNG Salva come JPEG
Città #
Singapore 1.549
Ashburn 1.401
Dublin 1.070
San Jose 1.021
Jacksonville 970
Chandler 885
Santa Clara 671
Beijing 651
Council Bluffs 631
Dallas 593
Hong Kong 582
Ho Chi Minh City 504
Dearborn 403
Boardman 364
Johannesburg 357
Hanoi 355
Nanjing 341
Ann Arbor 332
Princeton 261
Bremen 260
San Mateo 248
Lauterbourg 229
Parma 227
Munich 208
New York 202
Los Angeles 188
Toronto 171
Vienna 163
Helsinki 153
Izmir 149
Wilmington 139
Shanghai 128
Des Moines 119
Shenyang 114
Hefei 112
São Paulo 109
Moscow 97
Kunming 95
Hebei 93
Nanchang 87
Buffalo 80
Haiphong 75
Jinan 69
Milan 63
Da Nang 62
Woodbridge 60
Fortaleza 59
Seattle 59
Marseille 54
Columbus 52
Grafing 51
Turku 51
Atlanta 49
Guangzhou 49
Changsha 48
Tianjin 46
Tokyo 46
Düsseldorf 45
Brussels 43
Houston 42
Montreal 37
Phoenix 37
Rio de Janeiro 37
Orem 36
Rome 36
Jiaxing 35
The Dalles 35
Brooklyn 34
Quito 31
North Bergen 30
Denver 29
Frankfurt am Main 29
Hải Dương 29
Biên Hòa 28
Chennai 28
Fremont 28
Warsaw 28
Brasília 26
London 25
Norwalk 25
Seoul 25
Zhengzhou 25
Hangzhou 23
Nuremberg 23
Chicago 22
Jakarta 22
Porto Alegre 22
Tashkent 22
Curitiba 21
San Francisco 21
Washington 21
Bắc Ninh 20
Nairobi 20
Verona 20
Can Tho 19
Belo Horizonte 18
Boston 18
Guayaquil 18
Istanbul 18
Amsterdam 17
Totale 18.373
Salva come PNG Salva come JPEG
Nome #
Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study 370
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 305
A transphyletic anti-infectious control strategy based on the killer phenomenon. 289
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 282
Antibacterial effects of two synthetic peptides against Enterococcus faecalis biofilms: A preliminary in vitro study 261
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 246
Anti-Staphylococcus aureus Activity and Structural Characterization of Rationally Designed Peptides 243
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 222
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 219
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 217
Activity of two antimicrobial peptides against Enterococcus faecalis in a model of biofilm-mediated endodontic infection 212
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 210
A synthetic peptide as a novel anticryptococcal agent 206
Candidacidal activity of a novel killer toxin from Wickerhamomyces anomalus against fluconazole-susceptible and -resistant strains 205
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 203
Antibodies as a source of anti-infective peptides: an update 202
Antimicrobial peptide L18R displays a modulating action against inter-kingdom biofilms in the Lubbock chronic wound biofilm model 196
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 196
Metabolic profiling of Candida albicans 195
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 194
Activity of Synthetic Peptide KP and Its Derivatives against Biofilm-Producing Escherichia coli Strains Resistant to Cephalosporins 192
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 188
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 185
Antifungal activity of the C-terminal peptide from human serum albumin 183
Fungicidal activity of peptides encoded by immunoglobulin genes 181
Anticorpi immagini interne di tossine killer 181
Antimicrobial effect on candida albicans biofilm bapplication of different wavelengths and dyes and the synthetic killer decapeptide KP 177
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 177
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 176
Antifungal peptides within the antibodies 176
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 175
Valutazione del sistema Bactec Mycobacterial Growth Indicator Tube (MGIT) 960 per il rilevamento di micobatteri dai materiali patologici in comparazione ai metodi radiometrico e tradizionale 172
L’antibiogramma per i miceti 172
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 171
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 171
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 168
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 168
Novel Arginine- and Proline-Rich Candidacidal Peptides Obtained through a Bioinformatic Approach 167
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 166
Natural and synthetic peptides with antifungal activity 165
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 163
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 162
Peptides from the inside of the antibodies are active against infectious agents and tumours 162
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BIOFILMS WITH DIFFERENT WAVELENGTHS AND DYES WITH SYNTHETIC KILLER DECAPEPTIDE 161
Anaerobic yeast killer system. 160
Antibody peptide based antifungal immunotherapy 160
Antibody-mediated protective immunity in fungal infections 160
Mode of action of a killer peptide against Toxoplasma gondii 159
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 158
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 158
Antimicrobial photodynamic therapy protocols on streptococcus mutans with different combinations of wavelengths and photosensitizing dyes 156
Metabolic profile of Candida albicans 154
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 152
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 152
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 150
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 150
Antireceptor yeast killer toxin-like antibiobodies 148
Antibiobodies: antibiotic-like antiidiotypic antibodies. 148
Innate antimicrobial and antiviral activities of antibody peptides 147
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 147
The Variability of the Salivary Antimicrobial Peptide Profile: Impact of Lifestyle 146
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 145
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 145
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 145
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 145
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 144
Wickerhamomyces yeast killer toxins’ medical applications 144
Guideline for the analysis of the microbial communities of the human upper airways 143
Detection of Mycobacterium bovis in bovine tissue samples by the Abbott LCx Mycobacterium tuberculosis assay and comparison with culture methods 143
Antibiobodies: antibiotic internal image antibodies 143
A Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species 143
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 143
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 143
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 143
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 139
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 138
Allergic bronchopulmonary aspergillosis: An important cause of asthma which is sometimes ignored 138
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 135
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 135
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 134
Antibiotic antibodies 133
In vitro and in vivo anticandidal activity of killer peptide derivatives 132
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 131
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 130
A Wickerhamomyces anomalus killer strain in the malaria vector Anopheles stephensi 129
Restriction of Influenza virus multiplication induced by PK peptide treatment 128
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 128
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. 124
Marcatori epidemiologici. 123
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 123
Antibodies as Crypts of Antiinfective and Antitumor Peptides 121
Any antibody fragment might exert antifungal activity 121
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 120
Ogni frammento anticorpale può esplicare attività antinfettiva ed antitumorale. 120
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 118
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 118
Protective antifungal yeast killer toxin-like antibodies 117
Human natural yeast killer toxin-like antibodies 116
Yeast killer toxins and dimorphism. 116
Immagine interna del fenomeno killer dei lieviti 115
Totale 16.588
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.186 0 0 0 0 58 68 169 221 51 128 64 427
2022/20234.045 504 352 216 259 539 456 35 235 1.311 12 92 34
2023/20241.363 79 147 48 55 132 381 59 77 25 90 113 157
2024/20254.772 52 303 317 334 357 517 149 197 788 485 382 891
2025/202610.710 840 1.049 1.356 1.231 1.469 600 1.218 410 1.357 691 303 186
2026/20272.688 654 636 593 737 68 0 0 0 0 0 0 0
Totale 31.611